Related Experiment Video
Updated: Jan 19, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues
Junjie Zhang1, Fei Guo1, Lei Wang1
1Department of Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, Henan, China.
Insights
This study identified profilin-1 as a specific protein marker for childhood Wilms
Area of Science:
- Pediatric Oncology
- Proteomics
- Biomarker Discovery
Background:
- Wilms' tumor is a common pediatric malignancy requiring early diagnosis.
- Previous research utilized proteomics to find serum protein markers in Wilms' tumor patients.
- Identifying specific tumor markers is crucial for diagnosis and treatment.
Purpose of the Study:
- To identify specific protein markers for Wilms' tumor.
- To compare proteomic profiles of Wilms' tumor tissues and sera with normal kidney tissues and systemic inflammatory response syndrome (SIRS) controls.
Main Methods:
- Proteomic analysis using Surface-Enhanced Laser Desorption Ionization Time-of-Flight Mass Spectrometry (SELDI-TOF-MS).
- Protein purification via Sodium Dodecylsulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE).
- Protein identification using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight/Time-of-Flight (MALDI-TOF/TOF).
- Validation of expression using Real-Time Polymerase Chain Reaction (RT-PCR) and Enzyme-Linked Immunosorbent Assay (ELISA).
Main Results:
- SELDI-TOF-MS identified a specific protein marker (m/z 8350) in Wilms' tumor.
- The identified protein was confirmed as profilin-1.
- Profilin-1 expression was validated in Wilms' tumor samples.
Conclusions:
- Profilin-1 is a potential protein marker for Wilms' tumor.
- The employed proteomic methods are feasible for identifying tumor-specific markers.
- This finding supports improved diagnostic strategies for Wilms' tumor.
Abstract:
Wilms' tumor is one of the most common malignancies in children, and early diagnosis is critical for its subsequent treatment and prognosis. Our previous study employed proteomics to investigate protein markers in the serum of Wilms' tumor children. The present study aimed to identify specific protein markers in Wilms' tumor. Proteomic comparison of Wilms' tumor with normal kidney tissues and the sera of systemic inflammatory response syndrome (SIRS) controls was performed. Surface-enhanced laser desorption ionization time-of-flight (SELDI-TOF-MS) identified a protein with m/z 8350 as specific to Wilms' tumor. The target protein was purified using sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and identified as profilin-1 by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF). Its expression was validated using real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Our data identify profilin-1 as a potential protein marker for Wilms' tumor and demonstrate the feasibility of the above procedures for screening and identification of tumor-specific protein markers.

